Let the iPSC experts generate high-quality, induced pluripotent stem cells (iPSC) and derived physiologically relevant cell line models from your healthy/disease human or non-human samples. If you do not have a starting sample, Applied StemCell (ASC) offers customizable sample collection services. With our optimized reprogramming protocols and comprehensive characterization services, we deliver iPSCs ideal for your basic research, drug discovery, drug screening, and preclinical cell regeneration projects:
Not only can ASC further characterize your iPSCs, but our experts can also genetically engineer your iPSCs using CRISPR/Cas9 or TARGATT™ and differentiate the iPSCs to the cell type of your choice, including NK cells, T cells, astrocytes, cardiomyocytes, and more.
|Catalog ID#||Product Name||Price|
We ask that you send in pathogen test results before you send the blood samples to us.
If you do not have pathogen test results, you can send the blood samples to us directly, and we will do the sample process and culture in a quarantine room for 1-2 weeks before we submit and get pathogen test results. A quarantine room fee is applied. Inquire for more details.
For iPSC generation from patient fibroblasts, customers will need to provide 1 x 10^6 cells.
For iPSC generation from PBMCs, we will need 2 vials of 2-3 x 10^6 cells.
Yes, we can receive skin biopsy. The skin biopsy can be stored immediately after the collection and shipped overnight in PBS or complete medium (DMEM/10% FBS) at 4°C.
Turnaround time: 2-3 months
iPSCs characterized for morphology and pluripotency markers (OCT4, SOX2, SSEA4, TRA-1-60, TRA-1-81). Additional characterization such as G-banding, RT-PCR, STR profiling, directed differentiation is also available.